Home
Deep Intelligent Pharma

Deep Intelligent Pharma Market Share Analysis for June 2026

Industry: N/A

Domaindip-ai.com

Year Founded2017

Employees51 - 200

Annual Revenue--

Deep Intelligent Pharma

Deep Intelligent Pharma (including company regionals)

dip-ai.com

See more website traffic and engagement information

Total visits to Deep Intelligent Pharma's top domains

Understand Deep Intelligent Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

dip-ai.com4.7K

See more with Sales Intelligence

Avg. visit duration in Deep Intelligent Pharma's top domains

Analyze Deep Intelligent Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

dip-ai.com00:00:19

See more with Sales Intelligence

Avg. pageviews on Deep Intelligent Pharma's top domains

See how Deep Intelligent Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

dip-ai.com1.65

See more with Sales Intelligence

Deep Intelligent Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Deep Intelligent Pharma

These are the website technologies, by industry, used by Deep Intelligent Pharma top domains

Advertising (1)

Baidu Ads

Conversion & Analytics (1)

Baidu Analytics

eCommerce (1)

Swap

Email Services (1)

G Suite

More Technologies

2

See all

News & Signals from Deep Intelligent Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDeep Intelligent Pharma Co., Ltd. received financing of $60M in financing round on Feb 1st '26.Deep Intelligent Pharma (DIP), an AI-driven drug discovery unicorn, has recently completed a new US$60 million financing round.

NewsDeep Intelligent Pharma Co., Ltd. received financing of $50M in Series D on Dec 11th '25.On December 11, 2025, Deep Intelligent Pharma (DIP), a global leader in AI-driven drug development, announced that it has raised nearly US$50 million in Series D financing.